Addiction Portfolio
Substance Use Disorders
ApprovedActive
Key Facts
About Molteni Farmaceutici
Molteni Farmaceutici is a well-established, privately-held Italian pharmaceutical company with a 130+ year legacy, transitioning from its pharmacy origins to a modern drug developer and manufacturer. Its core business revolves around small molecule therapeutics and medical devices, targeting specific niches such as addiction medicine, pain management, and anesthesia. The company is in a commercial, revenue-generating stage, supported by a portfolio of approved products and a growing international footprint, notably in Poland. Its strategy combines deep therapeutic expertise with a commitment to sustainability and corporate responsibility.
View full company profileTherapeutic Areas
Other Substance Use Disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| Neuroplastogen Programs | Delix Therapeutics | Pre-clinical |
| TAAR1 Program | Newleos | Preclinical |
| Frenelle PBC Program | Frenelle Pharma | Preclinical |
| Conjugated Psiloc™ | Cynaptec Pharmaceuticals | Preclinical |